Skip to main content

Inpatient Burden and Mortality of Goodpasture's Syndrome in the United States: Nationwide Inpatient Sample 2003-2014.

Publication ,  Journal Article
Kaewput, W; Thongprayoon, C; Boonpheng, B; Ungprasert, P; Bathini, T; Chewcharat, A; Srivali, N; Vallabhajosyula, S; Cheungpasitporn, W
Published in: J Clin Med
February 6, 2020

Background: Goodpasture's syndrome is a rare, life-threatening, small vessel vasculitis. Given its rarity, data on its inpatient burden and resource utilization are lacking. We conducted this study aiming to assess inpatient prevalence, mortality, and resource utilization of Goodpasture's syndrome in the United States. Methods: The 2003-2014 National Inpatient Sample was used to identify patients with a principal diagnosis of Goodpasture's syndrome. The inpatient prevalence, clinical characteristics, in-hospital treatment, end-organ failure, mortality, length of hospital stay, and hospitalization cost were studied. Multivariable logistic regression was performed to identify independent factors associated with in-hospital mortality. Results: A total of 964 patients were admitted in hospital with Goodpasture's syndrome as the principal diagnosis, accounting for an overall inpatient prevalence of Goodpasture's syndrome among hospitalized patients in the United States of 10.3 cases per 1,000,000 admissions. The mean age of patients was 54 ± 21 years, and 47% were female; 52% required renal replacement therapy, whereas 39% received plasmapheresis during hospitalization. Furthermore, 78% had end-organ failure, with renal failure and respiratory failure being the two most common end-organ failures. The in-hospital mortality rate was 7.7 per 100 admissions. The factors associated with increased in-hospital mortality were age older than 70 years, sepsis, the development of respiratory failure, circulatory failure, renal failure, and liver failure, whereas the factors associated with decreased in-hospital mortality were more recent year of hospitalization and the use of therapeutic plasmapheresis. The median length of hospital stay was 10 days. The median hospitalization cost was $75,831. Conclusion: The inpatient prevalence of Goodpasture's syndrome in the United States is 10.3 cases per 1,000,000 admissions. Hospitalization of patients with Goodpasture's syndrome was associated with high hospital inpatient utilization and costs.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Clin Med

DOI

ISSN

2077-0383

Publication Date

February 6, 2020

Volume

9

Issue

2

Location

Switzerland

Related Subject Headings

  • 32 Biomedical and clinical sciences
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kaewput, W., Thongprayoon, C., Boonpheng, B., Ungprasert, P., Bathini, T., Chewcharat, A., … Cheungpasitporn, W. (2020). Inpatient Burden and Mortality of Goodpasture's Syndrome in the United States: Nationwide Inpatient Sample 2003-2014. J Clin Med, 9(2). https://doi.org/10.3390/jcm9020455
Kaewput, Wisit, Charat Thongprayoon, Boonphiphop Boonpheng, Patompong Ungprasert, Tarun Bathini, Api Chewcharat, Narat Srivali, Saraschandra Vallabhajosyula, and Wisit Cheungpasitporn. “Inpatient Burden and Mortality of Goodpasture's Syndrome in the United States: Nationwide Inpatient Sample 2003-2014.J Clin Med 9, no. 2 (February 6, 2020). https://doi.org/10.3390/jcm9020455.
Kaewput W, Thongprayoon C, Boonpheng B, Ungprasert P, Bathini T, Chewcharat A, et al. Inpatient Burden and Mortality of Goodpasture's Syndrome in the United States: Nationwide Inpatient Sample 2003-2014. J Clin Med. 2020 Feb 6;9(2).
Kaewput, Wisit, et al. “Inpatient Burden and Mortality of Goodpasture's Syndrome in the United States: Nationwide Inpatient Sample 2003-2014.J Clin Med, vol. 9, no. 2, Feb. 2020. Pubmed, doi:10.3390/jcm9020455.
Kaewput W, Thongprayoon C, Boonpheng B, Ungprasert P, Bathini T, Chewcharat A, Srivali N, Vallabhajosyula S, Cheungpasitporn W. Inpatient Burden and Mortality of Goodpasture's Syndrome in the United States: Nationwide Inpatient Sample 2003-2014. J Clin Med. 2020 Feb 6;9(2).

Published In

J Clin Med

DOI

ISSN

2077-0383

Publication Date

February 6, 2020

Volume

9

Issue

2

Location

Switzerland

Related Subject Headings

  • 32 Biomedical and clinical sciences
  • 1103 Clinical Sciences